P086 Clinical outcome and in vitro antifungal susceptibility of clinical isolates of rhino-orbito-cerebral mycosis associated with post COVID 19 from North India

POSTER SESSION 1, SEPTEMBER 21, 2022, 12:30 PM - 1:30 PM:   OBJECTIVES: This study aimed primarily to determine the etiology, clinical features, and comorbidities of patients with rhino-orbito-cerebral mycosis. Secondly, antifungal susceptibility pattern of the isolates and lineage by ITS-sequencing...

Descripción completa

Detalles Bibliográficos
Autores principales: Taneja, Juhi, Chatterjee, Kuhu, Sasidharan, Jaseetha, Abbas, Zafar, Rai, Anil K, Das, Bhabatosh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Oral Presentations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494483/
http://dx.doi.org/10.1093/mmy/myac072.P086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494483/
http://dx.doi.org/10.1093/mmy/myac072.P086

Ejemplares similares